NovoCure Ltd.

NovoCure Ltd. is a global oncology company focused on developing and commercializing Tumor Treating Fields, a non-invasive cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cell division. Its current commercial portfolio includes Optune Gio for glioblastoma and Optune Lua for malignant pleural mesothelioma, with these therapies used alongside standard cancer treatments in approved markets. The company operates across the United States, Europe, Japan, Greater China, and other international regions, supporting patients through portable device-based treatment systems and related services. NovoCure Ltd. plays a specialized role in the cancer care market by offering a device-led treatment platform for difficult-to-treat solid tumors, combining medical technology, clinical support, and oncology-focused commercialization.

Sector

Healthcare

Industry

Medical Devices

CEO

Mr. Frank Leonard

Employees

1,605

Headquarters

Baar, Switzerland

Website

www.novocure.com